Dianthus Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Dianthus Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Dianthus Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Dianthus Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $498k | 12k | 41.21 |
| 2024-06-30 | $263k | 10k | 25.88 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas